1973
DOI: 10.1172/jci107469
|View full text |Cite
|
Sign up to set email alerts
|

Antihemophilic Factor Antigen. LOCALIZATION IN ENDOTHELIAL CELLS BY IMMUNOFLUORESCENT MICROSCOPY

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

3
115
0
1

Year Published

1982
1982
2004
2004

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 422 publications
(119 citation statements)
references
References 35 publications
3
115
0
1
Order By: Relevance
“…The addition of either an intact HFN matrix or ECGF to the culture environment did not prevent, but significantly delayed the process of HUV-EC organization. The ceils involved in tube development were endothelial cells and not smooth muscle cell contaminants, as the tubular structures contained the factor VIII:Ag and Weibel-Palade bodies, two markers that are specific for endothelial cells (15,36). Furthermore, ceils derived from tubular structures by either trypsin digestion or tube explant methods grew to form a classic cobblestone endothelial cell monolayer and contained factor VIII:Ag.…”
Section: Discussionmentioning
confidence: 98%
“…The addition of either an intact HFN matrix or ECGF to the culture environment did not prevent, but significantly delayed the process of HUV-EC organization. The ceils involved in tube development were endothelial cells and not smooth muscle cell contaminants, as the tubular structures contained the factor VIII:Ag and Weibel-Palade bodies, two markers that are specific for endothelial cells (15,36). Furthermore, ceils derived from tubular structures by either trypsin digestion or tube explant methods grew to form a classic cobblestone endothelial cell monolayer and contained factor VIII:Ag.…”
Section: Discussionmentioning
confidence: 98%
“…With the advent of sophisticated immunological techniques, including monoclonal antibodies, it seems likely that (Hoyer et al, 1973) and monoclonal antibodies have recently been raised against this antigen (Sola et al, 1981). It should be possible to conjugate an S-phase-specific chemotherapeutic agent with an endothelial-cell-specific antibody, which could result in a large degree of cell killing in tumour capillaries with very little damage to any normal tissue vessels.…”
mentioning
confidence: 99%
“…In his studies, vWF antigen was present in endothelial cells in all tissues tested by immunofluorescence but was not present in smooth muscle cells or in fibroblasts (14). In collaboration with him, we studied the expression of vWF antigen by our cultured endothelial cells and were able to demonstrate that the cells in our culture all contained vWF, whereas vWF was absent in all cultured smooth muscle cells and fibroblasts.…”
Section: Figurementioning
confidence: 79%